67 results
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
and pharmacokinetics and optimize their formulation may produce unfavorable results;
patient recruitment and enrollment in clinical trials may
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
and pharmacokinetics and optimize their formulation may produce unfavorable results;
patient recruitment and enrollment in clinical trials may
424B5
SEEL
Seelos Therapeutics Inc
25 Sep 23
Prospectus supplement for primary offering
6:02am
recruitment and enrollment in clinical trials may be slower than we anticipate;
costs of development may be greater than we anticipate;
our product
424B5
sy24wd5 1knhvg9d
12 May 22
Prospectus supplement for primary offering
8:30am
424B5
0dvzrpi 6ftz6b3m
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
1w1 ypou9sf
19 May 21
Prospectus supplement for primary offering
4:08pm
424B5
n0xg2hllcpvy0tat9q0h
26 Jan 21
Prospectus supplement for primary offering
5:11pm
424B5
q0r7jb5vb3riyu
25 Jan 21
Prospectus supplement for primary offering
4:16pm